GC Biopharma will acquire ABO Holdings for $96 million to enhance its immunoglobulin medication Alyglo's supply chain.

Fintel reports that on December 11, 2024, Citigroup upgraded their outlook for Glaukos (NYSE:GKOS) from Neutral to Buy.

Hyderabad: Gland Pharma Limited, a generic injectable-focused pharmaceutical company, has received approval from the United ...

Gland Pharma shares soared up to 5 per cent in early trade after the US drug regulator approved the company's Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules.

Private equity firms Carlyle Group Inc.’s AlpInvest and Sixth Street are backing Essential Pharma as part of a €900 million ($945 million) recapitalization of the drugmaker.

Phathom Pharmaceuticals, Inc.'s vonoprazan received multiple approvals, but the stock price showed erratic behavior. Learn ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 22.22% ...

Danish pharma company Bavarian Nordic is shutting down its U.S.-based R&D site in San Diego and laying off all 48 employees ...

The company produces plant-based beverages in Canada and the United States. It could open a new facility in a Midlands county ...

Covetrus announced the expansion of its' site in Arizona, increasing the company’s pharmacy capabilities for producing ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Hepion Pharmaceuticals and Pharma Two B have terminated a reverse merger agreement that was expected to close by the end of ...